SBARS is found to distinguish between active LN patients and healthy individuals with a notable predictive accuracy, evidenced by AUC values of 0.9 for TNFRSF1b and 1.0 for VSIG4. This evidence concerns the gene VSIG4 and lobular neoplasia.